en

PRODUCT DETAIL

BRUFEN RETARD 800 mg

Code 23089
MA number 29/0659/10-S
Product Form: tbl flp 30x800 mg (blis. PVC/PVDC)
MA Status: D - Marketing Authorisation valid for an unlimited period
Type of procedure: National
MAH, country: Viatris Healthcare Limited, Ireland
Therapeutic Class: 29 - ANTIRHEUMATICA, ANTIPHLOGISTICA, ANTIURATICA
ATC:
M MUSCULO-SKELETAL SYSTEM
M01 ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
M01A ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-S
M01AE Propionic acid derivatives
M01AE01 Ibuprofen
Shelf life: 36
Route of admin.: Oral use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 8(3) application - known active substance
MA issued: 23.09.2010
Pediatric posology: Yes
Pediatric warnings: Yes
SPC: SPC_BRUFEN RETARD 800 mg_04.2024.pdf  
PIL: PIL_BRUFEN RETARD 800 mg_04.2024.pdf  
Safety feature Yes
Data update: 16.04.2018
eu-flag.png sk-flag.png